Pages that link to "Q47745301"
Jump to navigation
Jump to search
The following pages link to Blockade of programmed death-1 engagement accelerates graft-versus-host disease lethality by an IFN-gamma-dependent mechanism (Q47745301):
Displaying 50 items.
- Role of lymphocyte activation gene-3 (Lag-3) in conventional and regulatory T cell function in allogeneic transplantation (Q21132345) (← links)
- Genes, tolerance and systemic autoimmunity (Q24615454) (← links)
- Therapeutics for Graft-versus-Host Disease: From Conventional Therapies to Novel Virotherapeutic Strategies (Q26751959) (← links)
- Melanoma: oncogenic drivers and the immune system (Q26775598) (← links)
- Role of the PD-1 pathway in the immune response (Q26828748) (← links)
- The complex and central role of interferon-γ in graft-versus-host disease and graft-versus-tumor activity (Q26851545) (← links)
- The PD1:PD-L1/2 Pathway from Discovery to Clinical Implementation (Q28066941) (← links)
- Anti-programmed death receptor 1 immunotherapy in melanoma: rationale, evidence and clinical potential (Q28084942) (← links)
- Regulatory T cells and human myeloid dendritic cells promote tolerance via programmed death ligand-1. (Q33528964) (← links)
- Emerging treatment options for the management of Hodgkin's lymphoma: clinical utility of nivolumab (Q33704061) (← links)
- PD-1, gender, and autoimmunity (Q33910421) (← links)
- Alloantigen expression on non-hematopoietic cells reduces graft-versus-leukemia effects in mice. (Q33967995) (← links)
- Advances in graft-versus-host disease biology and therapy (Q34031916) (← links)
- Pharmacologic blockade of JAK1/JAK2 reduces GvHD and preserves the graft-versus-leukemia effect (Q34301568) (← links)
- Targeting of B and T lymphocyte associated (BTLA) prevents graft-versus-host disease without global immunosuppression (Q34340643) (← links)
- Allergen-responsive CD4+CD25+ regulatory T cells in children who have outgrown cow's milk allergy (Q34548646) (← links)
- PD-L1 blockade effectively restores strong graft-versus-leukemia effects without graft-versus-host disease after delayed adoptive transfer of T-cell receptor gene-engineered allogeneic CD8+ T cells (Q34557896) (← links)
- Antibody-mediated signaling through PD-1 costimulates T cells and enhances CD28-dependent proliferation. (Q34562561) (← links)
- PD-1-dependent mechanisms maintain peripheral tolerance of donor-reactive CD8+ T cells to transplanted tissue (Q34597955) (← links)
- The programmed death (PD)-1/PD-ligand 1 pathway regulates graft-versus-host-reactive CD8 T cells after liver transplantation (Q34598808) (← links)
- PDL1 is required for peripheral transplantation tolerance and protection from chronic allograft rejection (Q34697293) (← links)
- Pretransplant CSF-1 therapy expands recipient macrophages and ameliorates GVHD after allogeneic hematopoietic cell transplantation (Q34973719) (← links)
- HDAC inhibition and graft versus host disease (Q35016985) (← links)
- The link between the PDL1 costimulatory pathway and Th17 in fetomaternal tolerance. (Q35403407) (← links)
- siRNA silencing of PD-1 ligands on dendritic cell vaccines boosts the expansion of minor histocompatibility antigen-specific CD8(+) T cells in NOD/SCID/IL2Rg(null) mice (Q35546869) (← links)
- T-cell costimulatory pathways in allograft rejection and tolerance (Q35583511) (← links)
- Altering immune tolerance therapeutically: the power of negative thinking (Q35600811) (← links)
- A repertoire-independent and cell-intrinsic defect in murine GVHD induction by effector memory T cells (Q35604083) (← links)
- The PDL1-PD1 axis converts human TH1 cells into regulatory T cells (Q35607698) (← links)
- Mechanistic Assessment of PD-1H Coinhibitory Receptor-Induced T Cell Tolerance to Allogeneic Antigens (Q35613336) (← links)
- B7-H3 expression in donor T cells and host cells negatively regulates acute graft-versus-host disease lethality (Q35634896) (← links)
- PD-1 as an immune modulatory receptor. (Q35681585) (← links)
- Co-inhibitory molecules of the B7-CD28 family in the control of T-cell immunity (Q35762422) (← links)
- PD-1(hi)TIM-3(+) T cells associate with and predict leukemia relapse in AML patients post allogeneic stem cell transplantation. (Q35921900) (← links)
- The balance of immune responses: costimulation verse coinhibition (Q35998858) (← links)
- Programmed death-1 controls T cell survival by regulating oxidative metabolism. (Q36036001) (← links)
- CD28 family and chronic rejection: "to belatacept...And beyond!". (Q36037639) (← links)
- Contrasting acute graft-versus-host disease effects of Tim-3/galectin-9 pathway blockade dependent upon the presence of donor regulatory T cells (Q36106330) (← links)
- Pathogenesis of acute graft-versus-host disease: from intestinal microbiota alterations to donor T cell activation (Q36130498) (← links)
- Pathophysiology of acute graft-versus-host disease: recent advances (Q36156559) (← links)
- Programmed death-1 (PD-1) defines a transient and dysfunctional oligoclonal T cell population in acute homeostatic proliferation (Q36228974) (← links)
- A novel recognition system for MHC class I molecules constituted by PIR. (Q36287479) (← links)
- Immunotherapy following hematopoietic stem cell transplantation: potential for synergistic effects (Q36380188) (← links)
- Immunotherapies: the blockade of inhibitory signals (Q36431677) (← links)
- Local expression of B7-H1 promotes organ-specific autoimmunity and transplant rejection (Q36441358) (← links)
- Analysis of a Genetic Polymorphism in the Costimulatory Molecule TNFSF4 with Hematopoietic Stem Cell Transplant Outcomes (Q36551882) (← links)
- The role of checkpoints in the treatment of GBM (Q36571197) (← links)
- The role of B7 family molecules in hematologic malignancy (Q36584814) (← links)
- Physiologic regulation of central and peripheral T cell tolerance: lessons for therapeutic applications (Q36593312) (← links)
- Regulatory and conventional CD4+ T cells show differential effects correlating with PD-1 and B7-H1 expression after immunotherapy (Q36692284) (← links)